Wilson disease: Clinical presentation, treatment, and survival

Annals of Internal Medicine

Volumn 115, Issue 9, 1991, Pages 720-726

  Stremmel, Wolfgang ^a   Meyerrose, Karl Wilhelm ^a   Niederau, Claus ^a   Hefter, Harald ^a   Kreuzpaintner, Georg ^a   Strohmeyer, Georg ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; PENICILLAMINE; TRIENTINE;

ADOLESCENT; ADULT; BRAIN INJURY; DRUG EFFICACY; FOLLOW UP; GENETICS; HEPATOSPLENOMEGALY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NEPHROSIS; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN DISEASE; SURVIVAL; SYMPTOMATOLOGY; WILSON DISEASE;

ADOLESCENT; FEMALE; FOLLOW-UP STUDIES; HEPATOLENTICULAR DEGENERATION; HUMAN; LIVER TRANSPLANTATION; MALE; PENICILLAMINE; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0026076817     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-115-9-720     Document Type: Review

References (27)

1. Bachmann H, Lössner J, Gruss B, Ruchholtz U. Die Epidemiologie der Wilsonschen Erkrankung in der DDR und die derzeitige Problematik einer populationsgenetischen Bearbeitung. Psychiatr Neurol Med Psychol (Leipzig). 1979;31:393-400.
2. Frydman M, Bonné-Tamir B, Farrer LA, Conneally PM, Magazanik A, Ashbel S, et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci USA. 1985;82:1819-21.
3. Gibbs K, Walshe JM. Biliary excretion of copper in Wilson's disease [Letter). Lancet. 1980;2:538-9.
4. Czaja MJ, Weiner FR, Schwarzenberg SJ, Sternlieb I, Scheinberg IH, Van Thiel DH, et al. Molecular studies of ceruloplasmin deficiency in Wilson's disease. J Clin Invest. 1987;80:1200-4.
5. Walshe JM. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956;21:487-95.
6. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet. 1982;1:643-7.
7. Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med. 1987;317:209-13.
8. Walshe JM. Copper: its role in the pathogenesis of liver disease. Semin Liver Dis. 1984;4:252-63.
9. Hoogenraad TU, Van Hattum J, Van den Hamer CJ. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci. 1987;77:137-46.
10. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Am Intern Med. 1983;99:314-9.
11. 4) as an anti-copper agent in man. In: Scheinberg IH, Walshe JM; eds. Orphan Diseases and Orphan Drugs. Manchester, England: Manchester University Press; 1986:76-85.
12. Niederen C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313:1256-62.
13. Strohmeyer G, Stremmel W. Dietary factors in hemochromatotis. Wilson's disease and intermittent acute porphyria. In: Holm E. Kasper H; eds. Metabolism and Nutrition in Liver Disease. Boston: MTP Press Ltd.; 1984:211-9.
14. 2. Dtsch Med Wochenschr. 1980;105:483-8.
15. Kreuzpainter G, Stremmel W, Wesch H, Lauchart W, Feist D, Wittekind C, et al. Ist der M. Wilson durch Lebertransplantation heilbar? Klin Wochenschr. 1990;68(Suppl):60.
16. Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
17. Edwards CQ, Williams DM, Cartwright GE. Hereditary hypoceruloplasminemia. Clin Genet. 1979;15:311-6.
18. Popper H, Goldfischer S, Sternlieb I, Nayak NC, Madhavan TV. Cytoplasmic copper and its toxic effects. Studies in Indian childhood cirrhosis. Lancet. 1979;1:1205-8.
19. Sternlieb I, Scheinberg IH. The role of radiocopper in the diagnosis of Wilson's disease. Gastroenterology. 1979;77:138-42.
20. Bonné-Tamir, Frydman M, Agger MS, Bekeer R, Bowcock AM, Hebert JM, et al. Wilson's disease in Israel: a genetic and epidemiological study. Ann Hum Genet. 1990;54:155-68.
21. Halverson PB, Kozin F, Bernhard GC, Goldman AL. Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis. JAMA. 1978;240:1870-1.
22. Walshe JM. Pregnancy in Wilson's disease. Q J Med. 1977;46:73-83.
23. Scheinberg IH, Sternlieb I. Pregnancy in penicillamine-treated patients with Wilson's disease. N Engl J Med. 1975;293:1300-2.
24. Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med. 1973;42:441-52.
25. Van den Hamer CJ, Hoogenraad TU. Copper deficiency in Wilson's disease (Letter). Lancet. 1989;2:442.
26. Brewer GJ, Hill G, Prasad A, Dick R. The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper. Proc Soc Exp Biol Med. 1987;184:446-55.
27. Walshe JM. Diagnosis and treatment of presymptomatic Wilson's disease. Lancet. 1988;2:435-7.